{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:47:15Z","timestamp":1788425235747,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ymgme.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:45:14Z","timestamp":1535024714000},"page":"217-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria"],"prefix":"10.1016","volume":"125","author":[{"given":"Roberto","family":"Zori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Shur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orli","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Schweighardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3743-8044","authenticated-orcid":false,"given":"Kevin","family":"Larimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3677-1216","authenticated-orcid":false,"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.06.010_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1637","article-title":"Hyperphenylalaninemia: phenylalanine hydroxylase deficiency","author":"Scriver","year":"2001"},{"issue":"4","key":"10.1016\/j.ymgme.2018.06.010_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/13803390600745829","article-title":"A neuropsychological profile of off-diet adults with phenylketonuria","volume":"29","author":"Moyle","year":"2007","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"1","key":"10.1016\/j.ymgme.2018.06.010_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-010-9253-9","article-title":"High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial","volume":"34","author":"ten Hoedt","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2018.06.010_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev. Neuropsychol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2018.06.010_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2014.07.009","article-title":"Inborn errors of metabolism identified via newborn screening: ten-year incidence data and costs of nutritional interventions for research agenda planning","volume":"113","author":"Therrell","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2018.06.010_bb0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2018.06.010_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10545-010-9073-y","article-title":"The reality of dietary compliance in the management of phenylketonuria","volume":"33","author":"MacDonald","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2018.06.010_bb0040","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2013.10","article-title":"Newborn screening 50\u202fyears later: access issues faced by adults with PKU","volume":"15","author":"Berry","year":"2013","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2018.06.010_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.psym.2012.04.010","article-title":"A neuropsychiatric perspective of phenylketonuria I: overview of phenylketonuria and its neuropsychiatric sequelae","volume":"53","author":"Bone","year":"2012","journal-title":"Psychosomatics"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2018.06.010_bb0050","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ymgme.2009.10.182","article-title":"Psychiatric symptoms and disorders in phenylketonuria","volume":"99","author":"Brumm","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"2\u20133","key":"10.1016\/j.ymgme.2018.06.010_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","author":"Enns","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2018.06.010_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2017.01.001","article-title":"Adherence to clinic recommendations among patients with phenylketonuria in the United States","volume":"120","author":"Jurecki","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2018.06.010_bb0065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2018.06.010_bb0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.06.010_bb0075","series-title":"Tablets Prescribing Information","author":"Kuvan [sapropterin dihydrochloride]","year":"2007"},{"issue":"5","key":"10.1016\/j.ymgme.2018.06.010_bb0080","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1073\/pnas.96.5.2339","article-title":"A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase","volume":"96","author":"Sarkissian","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.ymgme.2018.06.010_bb0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/bms.1200110609","article-title":"The metabolism of cinnamic acid by healthy and phenylketonuric adults: a kinetic study","volume":"11","author":"Hoskins","year":"1984","journal-title":"Biomed. Mass Spectrom."},{"issue":"4","key":"10.1016\/j.ymgme.2018.06.010_bb0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jmb.2008.05.025","article-title":"Structural and biochemical characterization of the therapeutic Anabaena variabilis phenylalanine ammonia lyase","volume":"380","author":"Wang","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ymgme.2018.06.010_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173269","article-title":"Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"12","author":"Bell","year":"2017","journal-title":"PLoS One"},{"issue":"9937","key":"10.1016\/j.ymgme.2018.06.010_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(13)61841-3","article-title":"Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial","volume":"384","author":"Longo","year":"2014","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2018.06.010_bb0105","first-page":"S116","article-title":"Evaluation of multiple dosing regimens in phase 2 studies of rAvPAL-PEG for control of blood phenylalanine levels in adults with phenylketonuria [abstract]","volume":"38","author":"Adams","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.06.010_bb0110","article-title":"Evaluation of long-term safety and efficacy of pegvaliase treatment for adults with phenylketonuria: updated year 4 results [abstract]","volume":"39","author":"Longo","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.06.010_bb0115","series-title":"Common Terminology Criteria for Adverse Events, v4.03. NIH Publication #09-7473","year":"2010"},{"issue":"2","key":"10.1016\/j.ymgme.2018.06.010_bb0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymgme.2018.06.010_bb0125","author":"MedDRA 16.1, MSSO-DI-6001-16.1.0"},{"issue":"2","key":"10.1016\/j.ymgme.2018.06.010_bb0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report - second National Institute ofAllergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.ymgme.2018.06.010_bb0135","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.108.4.972","article-title":"Phenylketonuria: screening and management, October 16\u201318, 2000","volume":"108","author":"National Institutes of Health Consensus Development Conference Statement","year":"2001","journal-title":"Pediatrics"},{"issue":"2 Suppl 2","key":"10.1016\/j.ymgme.2018.06.010_bb0140","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.ymgme.2018.06.010_bb0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20052036","article-title":"T-independent type II immune responses generate memory B cells","volume":"203","author":"Obukhanych","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2018.06.010_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fimmu.2016.00021","article-title":"Immunogenicity to biotherapeutics \u2013 the role of anti-drug immune complexes","volume":"7","author":"Krishna","year":"2016","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.ymgme.2018.06.010_bb0155","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","article-title":"Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics","volume":"19","author":"Verhoef","year":"2014","journal-title":"Drug Discov. Today"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T04:12:50Z","timestamp":1540527170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1096719218300088"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.06.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}